Connect with us

The Plunge Daily

Serum Institute applies for emergency use authorisation for COVID-19 vaccine

COVID19

Serum Institute applies for emergency use authorisation for COVID-19 vaccine

Vaccine manufacturing major Serum Institute of India (SII) on Monday said it has applied to Drugs Controller General of India (DCGI) for emergency use authorisation for its COVID-19 vaccine Covishield. The Pune-based company has collaborated with Oxford University and pharmaceutical company Astra Zeneca for making the vaccine and is conducting trials in India.




“As promised, before the end of 2020, @SerumInstIndia has applied for emergency use authorisation for the first made-in-India vaccine, Covishield,” SII CEO Adar Poonawala said in a tweet. He further said: “This will save countless lives, and I thank the Government of India and Sri @narendramodi ji for their invaluable support.”


Also read:  Pfizer seeks from DCGI to import COVID-19 vaccine for sale and distribution across India

Last week, Pfizer India said it has applied to India’s drug regulator DCGI for emergency-use authorisation for its COVID-19 vaccine, after the company’s parent received clearance for the treatment from Britain and Bahrain.


Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

To Top
Loading...